1. Home
  2. TYRA vs HTLD Comparison

TYRA vs HTLD Comparison

Compare TYRA & HTLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • HTLD
  • Stock Information
  • Founded
  • TYRA 2018
  • HTLD 1978
  • Country
  • TYRA United States
  • HTLD United States
  • Employees
  • TYRA N/A
  • HTLD N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • HTLD Trucking Freight/Courier Services
  • Sector
  • TYRA Health Care
  • HTLD Industrials
  • Exchange
  • TYRA Nasdaq
  • HTLD Nasdaq
  • Market Cap
  • TYRA 576.6M
  • HTLD 685.0M
  • IPO Year
  • TYRA 2021
  • HTLD N/A
  • Fundamental
  • Price
  • TYRA $10.47
  • HTLD $9.22
  • Analyst Decision
  • TYRA Strong Buy
  • HTLD Sell
  • Analyst Count
  • TYRA 7
  • HTLD 4
  • Target Price
  • TYRA $30.86
  • HTLD $9.75
  • AVG Volume (30 Days)
  • TYRA 364.1K
  • HTLD 458.8K
  • Earning Date
  • TYRA 08-06-2025
  • HTLD 07-22-2025
  • Dividend Yield
  • TYRA N/A
  • HTLD 0.84%
  • EPS Growth
  • TYRA N/A
  • HTLD N/A
  • EPS
  • TYRA N/A
  • HTLD N/A
  • Revenue
  • TYRA N/A
  • HTLD $996,611,000.00
  • Revenue This Year
  • TYRA N/A
  • HTLD N/A
  • Revenue Next Year
  • TYRA N/A
  • HTLD $7.04
  • P/E Ratio
  • TYRA N/A
  • HTLD N/A
  • Revenue Growth
  • TYRA N/A
  • HTLD N/A
  • 52 Week Low
  • TYRA $6.42
  • HTLD $7.11
  • 52 Week High
  • TYRA $29.60
  • HTLD $13.67
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 58.12
  • HTLD 57.24
  • Support Level
  • TYRA $9.93
  • HTLD $8.90
  • Resistance Level
  • TYRA $10.49
  • HTLD $9.66
  • Average True Range (ATR)
  • TYRA 0.59
  • HTLD 0.27
  • MACD
  • TYRA 0.08
  • HTLD 0.06
  • Stochastic Oscillator
  • TYRA 94.30
  • HTLD 64.52

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About HTLD Heartland Express Inc.

Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.

Share on Social Networks: